← Back to Clinical Trials
Recruiting NCT06910176

NCT06910176 Confirming And Notifying Death

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06910176
Status Recruiting
Phase —
Sponsor University Hospital, Strasbourg, France
Condition Death Records
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2024-10-10
Primary Completion 2025-12-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2024-10-10 with a primary completion date of 2025-12-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Most physicians are confronted with the death of patients during their practice, often as early as residency. It is their legal responsibility to certify a patient's death, as well as often to notify their loved ones. Yet, these duties currently receive little or no specific training during the various cycles of medical education. This task is not easy, however, and young professionals experience it with difficulty. Literature data show that residents are confronted with death late in their medical education and that they are insufficiently prepared when they have to perform their first death certificate. Indeed, residents report significantly correlated practical and emotional difficulties. These difficulties are notably linked to a feeling of lack of preparation through theoretical courses, a lack of familiarity with administrative procedures, and insufficient mastery of communicating with families. The highlighting of these difficulties and the desire for appropriate and respectful care for the deceased and their families, for whom the moment of announcement influences the experience of grief, call for an improvement in teaching on these topics. It is in this sense that the project was born to explore whether the creation of training, before their independent exposure to death and its announcement, i.e. at the end of the second cycle, was relevant. A prerequisite for this type of training project is indeed to question the acceptability of such an approach by students.

Eligibility Criteria

Inclusion Criteria: * DFASM3 student, * At the Faculty of Medicine of Strasbourg, France, for the 2023-2024 academic year, * Having taken the national ECOS (thus becoming an intern at the start of the following academic year in November 2024), * Aged 18 years or older, * Not opposed to participating in the study. * Not having completed an internship in specialized palliative care facilities Exclusion Criteria: * Refused to participate in the study. * Not having taken the national ECOS.

Contact & Investigator

Central Contact

Catherine CHEVALIER-LAMOUILLE, MD

✉ catherine.lamouille@chru-strasbourg.fr

📞 33 3 88 11 65 86

Frequently Asked Questions

Who can join the NCT06910176 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Death Records. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06910176 currently recruiting?

Yes, NCT06910176 is actively recruiting participants. Contact the research team at catherine.lamouille@chru-strasbourg.fr for enrollment information.

Where is the NCT06910176 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT06910176 clinical trial?

NCT06910176 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology